BJCT-BIOJECT-needle less injection product Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BJCT-BIOJECT-needle less injection product

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: geewiz who wrote (185)	5/21/1998 11:52:00 PM
From: Marc Kahn	Read Replies (1) of 534

The Q4 and FY98 numbers are in. See biz.yahoo.com My most watched figure, the revenue from product sales, was $135,000 This is the lowest quarterly product sales number in my memory, "reflecting a change in the company's focus from its low-margin public health business." Jim O'Shea says, "Our results represent a shift in our strategic focus toward building corporate alliances that we expect will create lucrative new markets for our technologies. We're making considerable progress on this front, with a number of near- and long-term prospects currently under review." Mike Temple says, "As part of our strategic realignment, we have reduced our direct sales force and will focus on leveraging the sales and marketing capabilities of our corporate partners." It appears that we've thrown in the towel on Bioject marketing the Biojector products directly to health care providers. Even though we found a receptive market (in public health inoculations), we couldn't make a worthwhile profit! Now it will be up to our "corporate partners" to market our injection technology. Jim's comment foreshadows some announcement(s) of new alliances. However, this has been foreshadowed for a long time. I'm looking forward to examining the other shoe, when it finally drops. I have the utmost faith in Jim O'Shea's ability to lead our company forward. I'm disappointed and impatient, but hope springs eternal. Marc Kahn

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next